MMP9 and Parkinson disease: There were statistically significant differences in MMP9 levels among the three groups (early-stage PD patients, advanced-stage PD patients and healthy controls) [503 (390, 729) vs. 564 (504, 769) vs. 329 (229, 473) ng/ml P < 0.001].